It is not approved for any human therapeutic, diagnostic, or clinical application
Weight loss as monotherapy is minimal, averaging 2-4 additional pounds monthly versus placebo in controlled settings
Some of the most common symptoms include: Neurological problems, such as seizures, developmental delay, and intellectual disability Liver dysfunction, which can lead to jaundice and an enlarged liver Hemolytic anemia, which is a condition in which red blood cells are destroyed faster than they can be produced Low muscle tone Delayed growth and development Respiratory problems If you or your child is experiencing any of these symptoms, it is important to speak with a doctor as soon as possible to determine the underlying cause
Since retatrutide showed promising results during Phase 1 and 2 trials, researchers are now moving on to Phase 3
Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, et al
They're essentially chains of molecules called amino acids the same molecules that make up proteins
